Increased Risk of Deep Vein Thrombosis and Pulmonary Thromboembolism in Patients With Organophosphate Intoxication: A Nationwide Prospective Cohort Study
Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication.We identified pat...
Saved in:
Published in | Medicine (Baltimore) Vol. 94; no. 1; p. e341 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Authors. Published by Wolters Kluwer Health, Inc. Health, Inc. All rights reserved
01.01.2015
Wolters Kluwer Health |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication.We identified patients with OP intoxication by using the Taiwan National Health Insurance Research Database and enrolled 9223 patients who were hospitalized for OP intoxication between 2000 and 2011. OP intoxication was diagnosed based on a clinical assessment and serum acetylcholinesterase levels at the time of hospital admission. Each patient in the OP intoxication cohort was randomly frequency matched with 4 patients without OP intoxication based on their age, sex, and index year (36,892 patients as control cohort), and all patients were observed from the index date until the appearance of a DVT or a PTE event, or until December 31, 2011. We analyzed the risks of DVT and PTE by using Cox proportional hazards regression models that included the demographic variables of sex, age, and comorbidities (eg, hypertension, diabetes, cerebral vascular disease, heart failure, all cancer types, and lower leg fracture or surgery).The results revealed a significantly increased risk of developing DVT among patients with OP poisoning (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.03-2.34) but not PTE (adjusted HR = 1.44; 95% CI = 0.83-2.52). Among the patients without comorbidities, the OP poisoning patients compared with controls had a higher adjusted HR of 2.12 (95% CI = 1.21-3.71) for DVT.The results of this nationwide cohort study indicate that the risk of developing DVT is markedly higher in patients with OP intoxication compared with that of the general population. |
---|---|
AbstractList | Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication.We identified patients with OP intoxication by using the Taiwan National Health Insurance Research Database and enrolled 9223 patients who were hospitalized for OP intoxication between 2000 and 2011. OP intoxication was diagnosed based on a clinical assessment and serum acetylcholinesterase levels at the time of hospital admission. Each patient in the OP intoxication cohort was randomly frequency matched with 4 patients without OP intoxication based on their age, sex, and index year (36,892 patients as control cohort), and all patients were observed from the index date until the appearance of a DVT or a PTE event, or until December 31, 2011. We analyzed the risks of DVT and PTE by using Cox proportional hazards regression models that included the demographic variables of sex, age, and comorbidities (eg, hypertension, diabetes, cerebral vascular disease, heart failure, all cancer types, and lower leg fracture or surgery).The results revealed a significantly increased risk of developing DVT among patients with OP poisoning (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.03-2.34) but not PTE (adjusted HR = 1.44; 95% CI = 0.83-2.52). Among the patients without comorbidities, the OP poisoning patients compared with controls had a higher adjusted HR of 2.12 (95% CI = 1.21-3.71) for DVT.The results of this nationwide cohort study indicate that the risk of developing DVT is markedly higher in patients with OP intoxication compared with that of the general population. Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication.We identified patients with OP intoxication by using the Taiwan National Health Insurance Research Database and enrolled 9223 patients who were hospitalized for OP intoxication between 2000 and 2011. OP intoxication was diagnosed based on a clinical assessment and serum acetylcholinesterase levels at the time of hospital admission. Each patient in the OP intoxication cohort was randomly frequency matched with 4 patients without OP intoxication based on their age, sex, and index year (36,892 patients as control cohort), and all patients were observed from the index date until the appearance of a DVT or a PTE event, or until December 31, 2011. We analyzed the risks of DVT and PTE by using Cox proportional hazards regression models that included the demographic variables of sex, age, and comorbidities (eg, hypertension, diabetes, cerebral vascular disease, heart failure, all cancer types, and lower leg fracture or surgery).The results revealed a significantly increased risk of developing DVT among patients with OP poisoning (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.03-2.34) but not PTE (adjusted HR = 1.44; 95% CI = 0.83-2.52). Among the patients without comorbidities, the OP poisoning patients compared with controls had a higher adjusted HR of 2.12 (95% CI = 1.21-3.71) for DVT.The results of this nationwide cohort study indicate that the risk of developing DVT is markedly higher in patients with OP intoxication compared with that of the general population.Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication.We identified patients with OP intoxication by using the Taiwan National Health Insurance Research Database and enrolled 9223 patients who were hospitalized for OP intoxication between 2000 and 2011. OP intoxication was diagnosed based on a clinical assessment and serum acetylcholinesterase levels at the time of hospital admission. Each patient in the OP intoxication cohort was randomly frequency matched with 4 patients without OP intoxication based on their age, sex, and index year (36,892 patients as control cohort), and all patients were observed from the index date until the appearance of a DVT or a PTE event, or until December 31, 2011. We analyzed the risks of DVT and PTE by using Cox proportional hazards regression models that included the demographic variables of sex, age, and comorbidities (eg, hypertension, diabetes, cerebral vascular disease, heart failure, all cancer types, and lower leg fracture or surgery).The results revealed a significantly increased risk of developing DVT among patients with OP poisoning (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.03-2.34) but not PTE (adjusted HR = 1.44; 95% CI = 0.83-2.52). Among the patients without comorbidities, the OP poisoning patients compared with controls had a higher adjusted HR of 2.12 (95% CI = 1.21-3.71) for DVT.The results of this nationwide cohort study indicate that the risk of developing DVT is markedly higher in patients with OP intoxication compared with that of the general population. Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the development of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) among patients admitted with OP intoxication. We identified patients with OP intoxication by using the Taiwan National Health Insurance Research Database and enrolled 9223 patients who were hospitalized for OP intoxication between 2000 and 2011. OP intoxication was diagnosed based on a clinical assessment and serum acetylcholinesterase levels at the time of hospital admission. Each patient in the OP intoxication cohort was randomly frequency matched with 4 patients without OP intoxication based on their age, sex, and index year (36,892 patients as control cohort), and all patients were observed from the index date until the appearance of a DVT or a PTE event, or until December 31, 2011. We analyzed the risks of DVT and PTE by using Cox proportional hazards regression models that included the demographic variables of sex, age, and comorbidities (eg, hypertension, diabetes, cerebral vascular disease, heart failure, all cancer types, and lower leg fracture or surgery). The results revealed a significantly increased risk of developing DVT among patients with OP poisoning (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.03–2.34) but not PTE (adjusted HR = 1.44; 95% CI = 0.83–2.52). Among the patients without comorbidities, the OP poisoning patients compared with controls had a higher adjusted HR of 2.12 (95% CI = 1.21–3.71) for DVT. The results of this nationwide cohort study indicate that the risk of developing DVT is markedly higher in patients with OP intoxication compared with that of the general population. |
Author | Ma, Wei-Chih Lin, Yen-Ning Lin, Cheng-Li Lim, Yun-Ping Hung, Dong-Zong Kao, Chia-Hung |
AuthorAffiliation | From the Department of Pharmacy (Y-PL, D-ZH, W-CM, Y-NL), College of Pharmacy, China Medical University; Department of Emergency (Y-PL, D-ZH), Toxicology Center; Management Office for Health Data (C-LL), China Medical University Hospital; College of Medicine (C-LL); Graduate Institute of Clinical Medical Science and School of Medicine (C-HK), College of Medicine, China Medical University; and Department of Nuclear Medicine and PET Center (C-HK), China Medical University Hospital, Taichung, Taiwan |
AuthorAffiliation_xml | – name: From the Department of Pharmacy (Y-PL, D-ZH, W-CM, Y-NL), College of Pharmacy, China Medical University; Department of Emergency (Y-PL, D-ZH), Toxicology Center; Management Office for Health Data (C-LL), China Medical University Hospital; College of Medicine (C-LL); Graduate Institute of Clinical Medical Science and School of Medicine (C-HK), College of Medicine, China Medical University; and Department of Nuclear Medicine and PET Center (C-HK), China Medical University Hospital, Taichung, Taiwan |
Author_xml | – sequence: 1 givenname: Yun-Ping surname: Lim fullname: Lim, Yun-Ping organization: From the Department of Pharmacy (Y-PL, D-ZH, W-CM, Y-NL), College of Pharmacy, China Medical University; Department of Emergency (Y-PL, D-ZH), Toxicology Center; Management Office for Health Data (C-LL), China Medical University Hospital; College of Medicine (C-LL); Graduate Institute of Clinical Medical Science and School of Medicine (C-HK), College of Medicine, China Medical University; and Department of Nuclear Medicine and PET Center (C-HK), China Medical University Hospital, Taichung, Taiwan – sequence: 2 givenname: Cheng-Li surname: Lin fullname: Lin, Cheng-Li – sequence: 3 givenname: Dong-Zong surname: Hung fullname: Hung, Dong-Zong – sequence: 4 givenname: Wei-Chih surname: Ma fullname: Ma, Wei-Chih – sequence: 5 givenname: Yen-Ning surname: Lin fullname: Lin, Yen-Ning – sequence: 6 givenname: Chia-Hung surname: Kao fullname: Kao, Chia-Hung |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25569651$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9u1DAQxiNURLeFJ0BCPnJJsWM7bjggVbv8WamlKyhwtBxn0pgmdmo7XfoovC3ubheVHrBl2fL8vm80MwfZnnUWsuwlwUcEV-LN2eIIP1yUkSfZjHBa5rwq2V42w7jguagE288OQviJMaGiYM-y_YLzsio5mWW_l1Z7UAEa9MWEK-RatAAY0XcwFl103g21CyYgZRu0mvrBWeVvdwFIpzdhQIldqWjAxoB-mNihc3-prBs7F8ZORUBLG90voxPj7Ft0gj5vXmvTAFr5BIGO5gbQ3HXOR_Q1Ts3t8-xpq_oAL-7vw-zbh_cX80_56fnH5fzkNNcMc5ErUlJSFyWQstW4rgvAlW7bquF1S46pqrHGJVekbgWuFdW15g00irSCNhVljB5m77a-41QP0OhUhFe9HL0ZUqnSKSP_jVjTyUt3I1mJi-PizuD1vYF31xOEKAcTNPS9suCmIEnJuBCUM5zQVw9z_U2ym0cCqi2gU1eCh1ZqEze9SqlNLwmWd7OXZwv5ePZJSx9pd_b_V7Gtau36CD5c9dMavOxA9bHb4FxURV5gwjFJO08_RNA_NgDE6A |
CitedBy_id | crossref_primary_10_1097_MD_0000000000002140 crossref_primary_10_1007_s40726_018_0092_x crossref_primary_10_1016_S2352_3026_15_00228_8 crossref_primary_10_1097_MD_0000000000001222 crossref_primary_10_3390_toxics11090741 crossref_primary_10_4070_kcj_2021_0213 crossref_primary_10_1016_j_taap_2022_116267 crossref_primary_10_3400_avd_ra_21_00026 crossref_primary_10_4103_UROS_UROS_33_18 crossref_primary_10_52547_ajcm_28_4_210 crossref_primary_10_22537_jksct_2023_00002 crossref_primary_10_1016_j_toxrep_2019_06_002 crossref_primary_10_1007_s12020_017_1373_7 crossref_primary_10_1186_s40478_025_01979_0 crossref_primary_10_1016_j_neuro_2022_02_001 crossref_primary_10_1515_aiht_2016_67_2776 crossref_primary_10_24326_as_2023_5078 crossref_primary_10_1515_biolog_2017_0106 |
Cites_doi | 10.1016/j.neuro.2012.02.002 10.1001/archinte.159.5.445 10.4161/cc.8.23.10068 10.1016/S1726-4901(08)70043-1 10.1155/2013/321213 10.1001/archinte.1994.00420130020005 10.1016/S0140-6736(11)61306-8 10.3109/15563650.2012.745939 10.1016/j.taap.2011.11.014 10.1182/blood-2013-05-427708 10.1111/j.1365-2141.2008.07323.x 10.1111/bcpt.12158 |
ContentType | Journal Article |
Copyright | The Authors. Published by Wolters Kluwer Health, Inc. Health, Inc. All rights reserved. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. 2015 |
Copyright_xml | – notice: The Authors. Published by Wolters Kluwer Health, Inc. Health, Inc. All rights reserved. – notice: Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1097/MD.0000000000000341 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-5964 |
EndPage | e341 |
ExternalDocumentID | PMC4602824 25569651 10_1097_MD_0000000000000341 00005792-201501010-00017 |
Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAGIX AAHPQ AAIQE AAMOA AAQKA AARTV AASCR AAWTL AAXQO AAYEP ABASU ABBUW ABCQX ABDIG ABFRF ABOCM ABVCZ ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY ADNKB ADPDF AE6 AEFWE AENEX AFBFQ AFDTB AGOPY AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BQLVK CS3 DIWNM DU5 E.X EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FD6 FIJ FL- GNXGY GQDEL GROUPED_DOAJ H0~ HLJTE HYE HZ~ H~9 IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C N9A N~7 N~B O9- OAG OAH OB2 OHH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OUVQU OVD OVDNE OVEED OVIDH OVLEI OWV OWW OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UNMZH V2I VVN W3M WOQ WOW X3V X3W XYM YFH YOC ZFV ZY1 .3C .55 .GJ 1CY 53G AAYXX ADFPA ADGHP AE3 AFFNX AFUWQ AHRYX BS7 BYPQX CITATION FW0 JF9 JG8 N4W N~M OCUKA ODA ORVUJ OWU P-K R58 T8P X7M XXN ZGI ZXP ACIJW CGR CUY CVF ECM EIF NPM 7X8 5PM ADSXY |
ID | FETCH-LOGICAL-c4057-a1631b26e16fc0bb2e09cff9d5bf183ab0c065a1bf70ba3cbc5deda1f73d93443 |
ISSN | 0025-7974 1536-5964 |
IngestDate | Thu Aug 21 18:37:07 EDT 2025 Fri Jul 11 06:19:31 EDT 2025 Thu Apr 03 06:52:52 EDT 2025 Tue Jul 01 01:21:09 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 Fri May 16 03:52:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4057-a1631b26e16fc0bb2e09cff9d5bf183ab0c065a1bf70ba3cbc5deda1f73d93443 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | http://dx.doi.org/10.1097/MD.0000000000000341 |
PMID | 25569651 |
PQID | 1645773540 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4602824 proquest_miscellaneous_1645773540 pubmed_primary_25569651 crossref_citationtrail_10_1097_MD_0000000000000341 crossref_primary_10_1097_MD_0000000000000341 wolterskluwer_health_00005792-201501010-00017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-January-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-January-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Medicine (Baltimore) |
PublicationTitleAlternate | Medicine (Baltimore) |
PublicationYear | 2015 |
Publisher | The Authors. Published by Wolters Kluwer Health, Inc. Health, Inc. All rights reserved Wolters Kluwer Health |
Publisher_xml | – name: The Authors. Published by Wolters Kluwer Health, Inc. Health, Inc. All rights reserved – name: Wolters Kluwer Health |
References | Zunec (R10-17-20210226) 2014; 114 Crinnion (R11-17-20210226) 2000; 5 Zoller (R8-17-20210226) 2012; 379 Eisenhardt (R14-17-20210226) 2009; 8 Lee (R15-17-20210226) 2013; 51 Yang (R3-17-20210226) 2007; 70 Kmiecik (R12-17-20210226) 2013; 43 Banks (R1-17-20210226) 2012; 33 Lionetto (R2-17-20210226) 2013; 2013 Bardin (R9-17-20210226) 1994; 154 Samad (R13-17-20210226) 2013; 122 Heit (R6-17-20210226) 1999; 159 Bagot (R7-17-20210226) 2008; 143 Abdollahi (R5-17-20210226) 2012; 258 |
References_xml | – volume: 33 start-page: 575 year: 2012 ident: R1-17-20210226 article-title: A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation publication-title: Neurotoxicology doi: 10.1016/j.neuro.2012.02.002 – volume: 159 start-page: 445 year: 1999 ident: R6-17-20210226 article-title: Predictors of survival after deep vein thrombosis and pulmonaryembolism: a population-based, cohort study publication-title: Arch Intern Med doi: 10.1001/archinte.159.5.445 – volume: 5 start-page: 432 year: 2000 ident: R11-17-20210226 article-title: Environmental medicine, part 4: pesticides - biologically persistent and ubiquitous toxins publication-title: Altern Med Rev – volume: 8 start-page: 3885 year: 2009 ident: R14-17-20210226 article-title: C-reactive protein: how conformational changes influence inflammatory properties publication-title: Cell Cycle doi: 10.4161/cc.8.23.10068 – volume: 70 start-page: 467 year: 2007 ident: R3-17-20210226 article-title: Intermediate syndrome following organophosphate insecticide poisoning publication-title: J Chin Med Assoc doi: 10.1016/S1726-4901(08)70043-1 – volume: 2013 start-page: 321213 year: 2013 ident: R2-17-20210226 article-title: Acetylcholinesterase as a biomarker in environmental and occupational medicine: new insights and future perspectives publication-title: Biomed Res Int doi: 10.1155/2013/321213 – volume: 43 start-page: 191 year: 2013 ident: R12-17-20210226 article-title: Influence of oxidative stress on tissue regeneration publication-title: Polim Med – volume: 154 start-page: 1433 year: 1994 ident: R9-17-20210226 article-title: Organophosphate and carbamate poisoning publication-title: Arch Intern Med doi: 10.1001/archinte.1994.00420130020005 – volume: 379 start-page: 244 year: 2012 ident: R8-17-20210226 article-title: Risk of pulmonaryembolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden publication-title: Lancet doi: 10.1016/S0140-6736(11)61306-8 – volume: 51 start-page: 29 year: 2013 ident: R15-17-20210226 article-title: The difference in C-reactive protein value between initial and 24 hours follow-up (D-CRP) data as a predictor of mortality in organophosphate poisoned patients publication-title: ClinToxicol (Phila doi: 10.3109/15563650.2012.745939 – volume: 258 start-page: 309 year: 2012 ident: R5-17-20210226 article-title: A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2011.11.014 – volume: 122 start-page: 3415 year: 2013 ident: R13-17-20210226 article-title: Inflammation, obesity, and thrombosis publication-title: Blood doi: 10.1182/blood-2013-05-427708 – volume: 143 start-page: 180 year: 2008 ident: R7-17-20210226 article-title: Virchow and his triad: a question of attribution publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07323.x – volume: 114 start-page: 344 year: 2014 ident: R10-17-20210226 article-title: In vivo evaluation of cholinesterase activity, oxidative stress markers, cyto- and genotoxicity of K048 oxime–a promising antidote against organophosphate poisoning publication-title: Basic Clin Pharmacol Toxicol doi: 10.1111/bcpt.12158 |
SSID | ssj0013724 |
Score | 2.2449815 |
Snippet | Organophosphate (OP) poisoning is a critical cause of morbidity and mortality worldwide. We conducted a nationwide longitudinal cohort study to investigate the... |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e341 |
SubjectTerms | Adult Aged Female Humans Male Middle Aged Observational Study Organophosphate Poisoning - complications Organophosphorus Compounds - toxicity Prospective Studies Pulmonary Embolism - chemically induced Pulmonary Embolism - epidemiology Taiwan - epidemiology Venous Thrombosis - chemically induced Venous Thrombosis - epidemiology |
Title | Increased Risk of Deep Vein Thrombosis and Pulmonary Thromboembolism in Patients With Organophosphate Intoxication: A Nationwide Prospective Cohort Study |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-201501010-00017 https://www.ncbi.nlm.nih.gov/pubmed/25569651 https://www.proquest.com/docview/1645773540 https://pubmed.ncbi.nlm.nih.gov/PMC4602824 |
Volume | 94 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF71QAgJIW7CUS0Sb2GLb9e8hSaoQg1UKD3oi-Vdr7FFsKPGURH_hH_LzK6POCmIEilWvF47lufz7szszDeEvPISE-c1mxncE8xJnJhxMFOY2DMEmCOuYymH2_ijd3DsfDhzzzY2byxFLS1Kvit-XplX8j9ShTaQK2bJXkOyzUWhAX6DfGELEobtP8kYXm6MKQed8XMVIT6UctY_kVnen6QXxXdeIN-ISghYTOG2MESuOiDhO8UKGdD3SJOrYixsmer0zGKWFvNZCpooOg2LH1kbBjLoazLtyyyWmGhQJ2vC2JKCMq9CEzuLxeNq_R612XfRtMx0cG_jgjjUFZ2_LHJ2VM-kqrkKCJD5V3aYtQDUw9OwgObzou0_VnrwqczYfpqly-4M011xZ6hS1IsSbne-22QGKFX8tMDwgXm_Sh_QWVr1QLq6i4VPlXcD117Qvd3JFFMlfANdHaieBXSp5Q7a9ZAubc3MVakH9e7a1KMpjcdDzYhZf5qTO5zeeMT1A4vhE0CWP5Xdb_qbZNsCcwfG6-1PJ6PRsF0P8y2nKT4Md17zZwX-myv-satjrRlO6_G_ty_1w_2mnu2SgjW5S-5UlhEdaJjfIxsyv09u1th5QH41aKeIdlokFNFOEe20RTsFtNMG7XQF7RT61miniHa6gna6jPa3dEBbrNMlrFONdaqw_pAcvx9N9g9YVViECbRPWARGiMktT5peIgzOLWkEIkmC2OUJTHERNwRo5pHJE9_gkS24cGMZR2bi23FgO479iGzlRS6fEMr3QL9zucUDJKJMRGBawnc4ty2Tx74b9YhViyIUFes-Fn-ZhnX0x3gYrsqvR143J8006czfu7-sZRzC5IArflEui8U8ND3H9X107fbIYy3z5oLIPRh4Lpztd9DQdEDi-e6RPEsVAb3joafG6RHWwU2oU7fDP6H76TX7PyO32hHiOdkqLxbyBZgAJd9RrrOd6i35DYeJBKM |
linkProvider | Ovid |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgk2ASQtxXrkZCfSIjFycmSH2omoxurKWi3YWnKHZsJVoXR03L2E_h3-KTS6FMIBEpSiSf5MXHx9-5fUbojSct2Nccw2QeN4gkicG0m2Lw9ybX7ohL7CrgNhp7w2NyeOaeNdUW0AsD3WdlsQePyk7DC5yHA47hrHc47Y7D02kv7w6mg97X7qT_Mazi1FAl0Q166ptcdvvjqv7Kpb6tdUADHqtK-II9vom2PdemegFvfz4Jw-BXvoHaZH24q4bYLT-RT9-NgprjsL0cYm3uYdeA6fX6yjuXCnLf5XlV-v7bBrZ_D91tkCfu16pyH90Q-QN0a9Tk1h-iH9pUQIW6SPCXrDzHSuJAiAKfiCzHs3ShLpgqsxLHeYInq7lW33hx1Q4Ifc-z8gJr2UlN1Vri02yZ4qrZUxWpKotU41p8kC_V9yZQ-AH3cU3MfZklAk8Wqm38xAOVascAQ5nj1SN0vB_OBkOjObjB4ID_jFiDPIvZnrA8yU3GbGH6XEo_cZnUJiRmJtfIJ7aYpCaLHc64m4gktiR1Et8hxHmMtnKVi12EmfYIicts5gPRn-S-ZXNKGHNsiyXUjTvIbqci4g2rORyuMY_a7PooiP6cvw56u_6oqEk9_i3-up3jSC8-yKjEuVCrMtK-pksphM466Ek95-sfAreb77n6a7qhDWsBIPbeHMmztCL4Jh54wqSDjA29ierW2Ohv2v30P-VfodvD2egoOjoYf3qGdmC0Di49R1vLxUq80HBryV42a-Unoa4gpA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBYlhTIYY_dlVw2Gn-bhi2zHAz-EOFnbLWlY0tuTsWQJm6ZWiJ11-Sn7tzvyJVvWMZjB2CBZGM6R9J3bJ4TeucJU-5qtG9RlOhEk0SmYKTrrGQzMEYdYlcNtPHEPT8nxhXOxh9qIqSo-K5Yf1KNaptWLOg5H2YXz4HimDWaD4FKbDM9nwUSb9j8NKze1SpLQpuEo2GhhIL-JUgtPgpafcRzWJIXtZas69_1eD4B8B-2fnA2H4a-4g2eR7SGvALVbnqK_D7O7l90CqLfzLO_eSBUDL66qFPjfNrLRfXSvQaC4X6vMA7TH84foYNzE2B-hH7BkqEx1nuCvWXGFpcAh50t8xrMcz9OVvKayyAoc5wmerhegxvFq0zZwuBdZcY2h77SmbC3weVamuCr6lMtUFssU8C0-ykv5vXEYfsR9XBN032QJx9OVbAtA8UCmYCBgle64eYxOR8P54FBvDnDQmcKBegxgz6SWy01XMINSixs-E8JPHCpgKYmpwQABxSYVnkFjm1HmJDyJTeHZiW8TYj9BnVzm_BnCFCxD4lCL-orwTzDftJhHKLUtkyaeE3eR1YoiYg27uTpkYxG1UfZxGP0pvy56v_1oWZN7_Lv721bGEUxCFVmJcy7XRQQ2p-N5yoXWRU9rmW8HVBxvvuvA196ONmw7KILv3ZY8Syuib-Iqi5h0kb6jN1FdIlv9n-P5Fqx0AOvNKq1BoY7n_9n_DTqAuRN9OZp8foHuqMbax_QSdcrVmr8C1FXS181U-QkBaSIw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Risk+of+Deep+Vein+Thrombosis+and+Pulmonary+Thromboembolism+in+Patients+With+Organophosphate+Intoxication%3A+A+Nationwide+Prospective+Cohort+Study&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Lim%2C+Yun-Ping&rft.au=Lin%2C+Cheng-Li&rft.au=Hung%2C+Dong-Zong&rft.au=Ma%2C+Wei-Chih&rft.date=2015-01-01&rft.pub=The+Authors.+Published+by+Wolters+Kluwer+Health%2C+Inc.+Health%2C+Inc.+All+rights+reserved&rft.issn=0025-7974&rft.volume=94&rft.issue=1&rft.spage=e341&rft.epage=e341&rft_id=info:doi/10.1097%2FMD.0000000000000341&rft.externalDocID=00005792-201501010-00017 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon |